Bodycote plc (FRA:21T)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.83B +38.0% |
| Revenue (ttm) | 858.58M +1.7% |
| Net Income | 67.59M +104.9% |
| EPS | 0.40 +114.5% |
| Shares Out | n/a |
| PE Ratio | 26.73 |
| Forward PE | 17.11 |
| Dividend | 0.27 (2.52%) |
| Ex-Dividend Date | Oct 1, 2026 |
| Volume | 766 |
| Open | 10.70 |
| Previous Close | 10.70 |
| Day's Range | 10.70 - 10.70 |
| 52-Week Range | 6.75 - 11.10 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 27, 2026 |
About Bodycote
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in Specialist Technologies and Precision Heat Treatment divisions. The company offers heat treatment services, including altering the microstructure of metals and alloys, which include steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot... [Read more]
Financial Performance
In 2025, Bodycote's revenue was 727.10 million, a decrease of -3.96% compared to the previous year's 757.10 million. Earnings were 54.90 million, an increase of 174.50%.
Financial numbers in GBP Financial StatementsNews
CVC drops Bodycote pursuit, clears path for Veritas' $2.5 billion takeover
Private equity firm CVC Advisers said on Monday it does not plan to make an offer for Bodycote , abandoning its pursuit of the British thermal processing services group.
Bodycote downgraded to Hold from Buy at Berenberg
Berenberg downgraded Bodycote (BYPLF) to Hold from Buy with a price target of 933 GBp, up from 900 GBp. The firm cites the company’s bid activity for the downgrade. Published…
Bodycote price target raised to 950 GBp from 750 GBp at RBC Capital
RBC Capital raised the firm’s price target on Bodycote (BYPLF) to 950 GBp from 750 GBp and keeps a Sector Perform rating on the shares.
Bodycote H1 Earnings Call Highlights
Bodycote LON: BOY reported first-half core organic revenue growth of 9.6%, supported by strong demand in aerospace and defense, industrial gas turbines (IGT), medical and semiconductor-related markets...
Bodycote Earnings Call Transcript: H1 2026
Strong first-half results driven by nearly 10% core organic revenue growth, led by Aerospace & Defense, IGT, and Medical, offsetting automotive weakness. Margins and EPS improved, with continued benefits from the Optimise program and a robust M&A pipeline supporting future growth.
Bodycote Quarterly report: H1 2026
Bodycote has published its H1 2026 quarterly earnings report on July 28, 2026.
Bodycote Slides: H1 2026
Bodycote has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 28, 2026.
Bodycote reinstated with a Sector Perform at RBC Capital
RBC Capital reinstated coverage of Bodycote (BYPLF) with a Sector Perform rating and 750 GBp price target The firm says bid interest from Apollo was short-lived. Bodycote would not be…
Bodycote reinstated with an Overweight at Barclays
Barclays reinstated coverage of Bodycote (BYPLF) with an Overweight rating and 820 GBp price target following Apollo’s confirmation that it does not intend to make a firm offer for the…
Bodycote price target raised to 960 GBp from 835 GBp at Deutsche Bank
Deutsche Bank analyst Thomas Elgar raised the firm’s price target on Bodycote (BYPLF) to 960 GBp from 835 GBp and keeps a Buy rating on the shares. Published first on…
Bodycote Earnings release: Trading update
Bodycote released its earnings on May 27, 2026, summarizing the period's financial results.
Bodycote price target lowered to 905 GBp from 920 GBp at Jefferies
Jefferies analyst Andy Douglas lowered the firm’s price target on Bodycote (BYPLF) to 905 GBp from 920 GBp and keeps a Buy rating on the shares. FY25 preliminary results were…
Bodycote price target raised to 700 GBp from 670 GBp at JPMorgan
JPMorgan raised the firm’s price target on Bodycote (BYPLF) to 700 GBp from 670 GBp and keeps a Neutral rating on the shares.
Bodycote downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Bodycote (BYPLF) to Sector Perform from Outperform with an unchanged price target of 775 GBp. The firm cites valuation for the downgrade.
Bodycote Earnings Call Transcript: H2 2025
Stable core revenues in 2025 with strong H2 momentum in Aerospace & Defense, while oil and gas and auto markets remained weak. Margin and EPS declined, but cash conversion and balance sheet stayed robust. 2026 outlook is for organic growth and margin expansion, led by aerospace and IGT.
Bodycote Annual report: H2 2025
Bodycote has published its H2 2025 annual report on March 11, 2026.
Bodycote Slides: H2 2025
Bodycote has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 11, 2026.
Bodycote Annual report: H2 2025
Bodycote has published its H2 2025 annual report on March 11, 2026.
Bodycote price target raised to 900 GBp from 800 GBp at Berenberg
Berenberg raised the firm’s price target on Bodycote (BYPLF) to 900 GBp from 800 GBp and keeps a Buy rating on the shares.
Bodycote upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Bodycote (BYPLF) to Overweight from Equal Weight with a price target of 765 GBp, up from 635 GBp. The group’s current Industrial Gas Turbines exposure to increasing data…
Bodycote price target lowered to 600 GBp from 610 GBp at JPMorgan
JPMorgan lowered the firm’s price target on Bodycote (BYPLF) to 600 GBp from 610 GBp and keeps a Neutral rating on the shares.
Bodycote price target raised to 860 GBp from 700 GBp at Deutsche Bank
Deutsche Bank analyst Thomas Elgar raised the firm’s price target on Bodycote (BYPLF) to 860 GBp from 700 GBp and keeps a Buy rating on the shares. Published first on…
Bodycote price target raised to 635 GBp from 560 GBp at Barclays
Barclays raised the firm’s price target on Bodycote (BYPLF) to 635 GBp from 560 GBp and keeps an Equal Weight rating on the shares.
Bodycote Earnings Call Transcript: H1 2025
Sequential revenue growth and strong execution offset tough end markets, with profit improvement expected in H2. Expanded Optimise program and targeted investments support medium-term growth, while aerospace and defence drive momentum.